ISABL

Our team has developed the technology to profile tumor biopsies with whole genome and transcriptome sequencing in clinically relevant timeframes... Our team brings together leaders in cancer genomics, molecular diagnostics, oncology, and biomarker development from top-tier institutions such as Memorial Sloan Kettering, Harvard, and Weill Cornell Medicine... We offer more comprehensive biomarker discovery - creating opportunities for better diagnosis for all patients.

Also known as: Isabl, Inc.

Primary location: New York United States